Literature DB >> 15917993

Proinflammatory effects of LIGHT through HVEM and LTbetaR interactions in cultured human umbilical vein endothelial cells.

Ying Hsin Chang1, Shie Liang Hsieh, Yee Chao, Yang Chieh Chou, Wan Wan Lin.   

Abstract

Members of the tumor necrosis factor (TNF) receptor (TNFR) superfamily are known to be potent mediators of immune responses. LIGHT is a member of the TNF superfamily, and its receptors have been identified as lymphotoxin beta receptor (LTbetaR), herpes virus entry mediator (HVEM), and decoy receptor 3 (DcR3). LIGHT can induce either cell death and/or NF-kappaB activation via its interaction with LTbetaR and/or HVEM. In this study, we investigated the effects of LIGHT in human umbilical vein endothelial cells (HUVECs). We demonstrated that both LTbetaR and HVEM, but not DcR3, are present in HUVECs, and LIGHT can induce the secretion of chemokines (IL-8 and GRO-alpha), cell surface expression of adhesion molecules (ICAM-1 and VCAM-1), PGI2 release, and COX-2 expression. However, the LIGHT mutein, LIGHT-R228E, which has been shown to exhibit binding specificity to LTbetaR, could not induce the secretion of GRO-alpha, PGI2, or the expression of COX-2. These results indicate that both LTbetaR and HVEM can discriminatively mediate the expression of different genes in HUVECs, and suggest that LIGHT is a proinflammatory cytokine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15917993     DOI: 10.1007/s11373-005-1360-5

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  11 in total

1.  Differential Contribution of NF-κB Signaling Pathways to CD4+ Memory T Cell Induced Activation of Endothelial Cells.

Authors:  Kim C M Jeucken; Charlotte C N van Rooijen; Yik Y Kan; Lotte A Kocken; Aldo Jongejan; Abraham C I van Steen; Jaap D van Buul; Henric K Olsson; Jan Piet van Hamburg; Sander W Tas
Journal:  Front Immunol       Date:  2022-06-13       Impact factor: 8.786

Review 2.  Non-Canonical (RANKL-Independent) Pathways of Osteoclast Differentiation and Their Role in Musculoskeletal Diseases.

Authors:  A Sabokbar; D J Mahoney; F Hemingway; N A Athanasou
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

3.  A crucial role for B and T lymphocyte attenuator in preventing the development of CD4+ T cell-mediated herpetic stromal keratitis.

Authors:  Likun Xia; Shengnan Zhang; Jiazi Zhou; Yan Li
Journal:  Mol Vis       Date:  2010-10-13       Impact factor: 2.367

4.  The control of tissue fibrosis by the inflammatory molecule LIGHT (TNF Superfamily member 14).

Authors:  Rana Herro; Michael Croft
Journal:  Pharmacol Res       Date:  2015-12-31       Impact factor: 7.658

5.  De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors.

Authors:  Anna Johansson-Percival; Bo He; Zhi-Jie Li; Alva Kjellén; Karen Russell; Ji Li; Irma Larma; Ruth Ganss
Journal:  Nat Immunol       Date:  2017-09-11       Impact factor: 25.606

6.  The interaction of monocytes with rheumatoid synovial cells is a key step in LIGHT-mediated inflammatory bone destruction.

Authors:  Satoru Ishida; Shoji Yamane; Saori Nakano; Toru Yanagimoto; Yukie Hanamoto; Miki Maeda-Tanimura; Tomoko Toyosaki-Maeda; Jun Ishizaki; Yoshiyuki Matsuo; Naoshi Fukui; Tsunetoshi Itoh; Takahiro Ochi; Ryuji Suzuki
Journal:  Immunology       Date:  2008-11-19       Impact factor: 7.397

7.  Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venules.

Authors:  Bo He; Arnaud Jabouille; Veronica Steri; Anna Johansson-Percival; Iacovos P Michael; Venkata Ramana Kotamraju; Reimar Junckerstorff; Anna K Nowak; Juliana Hamzah; Gabriel Lee; Gabriele Bergers; Ruth Ganss
Journal:  J Pathol       Date:  2018-04-20       Impact factor: 7.996

Review 8.  Accelerator or Brake: Immune Regulators in Malaria.

Authors:  Chunmei Cai; Zhiqiang Hu; Xiao Yu
Journal:  Front Cell Infect Microbiol       Date:  2020-12-10       Impact factor: 5.293

9.  A crucial role for HVEM and BTLA in preventing intestinal inflammation.

Authors:  Marcos W Steinberg; Olga Turovskaya; Raziya B Shaikh; Gisen Kim; Declan F McCole; Klaus Pfeffer; Kenneth M Murphy; Carl F Ware; Mitchell Kronenberg
Journal:  J Exp Med       Date:  2008-06-02       Impact factor: 14.307

10.  HVEM and CD160: Regulators of Immunopathology During Malaria Blood-Stage.

Authors:  Franziska Muscate; Nadine Stetter; Christoph Schramm; Julian Schulze Zur Wiesch; Lidia Bosurgi; Thomas Jacobs
Journal:  Front Immunol       Date:  2018-11-13       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.